drugset / Trial / NCT00614926
Modafinil for Treatment of Fatigue in ALS Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this pilot study is to evaluate whether modafinil is helpful in alleviating fatigue, low energy, drowsiness and difficulty concentrating among patients with amyotrophic lateral sclerosis (ALS), and to evaluate incidence and frequency of adverse events, if any.
Timeline
- Start
- 2006-06
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Modafinil | Small molecule | 100 mg | — |
| Subject | Modafinil | Small molecule | 300 mg | — |
Indications
No indication recorded.